Literature DB >> 21840719

Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies.

Andreas M Grabrucker1, Michael J Schmeisser, Michael Schoen, Tobias M Boeckers.   

Abstract

Intact synaptic homeostasis is a fundamental prerequisite for a healthy brain. Thus, it is not surprising that altered synaptic morphology and function are involved in the molecular pathogenesis of so-called synaptopathies including autism, schizophrenia (SCZ) and Alzheimer's disease (AD). Intriguingly, various recent studies revealed a crucial role of postsynaptic ProSAP/Shank scaffold proteins in all of the aforementioned disorders. Considering these findings, we follow the hypothesis that ProSAP/Shank proteins are key regulators of synaptic development and plasticity with clear-cut isoform-specific roles. We thus propose a model where ProSAP/Shank proteins are in the center of a postsynaptic signaling pathway that is disrupted in several neuropsychiatric disorders.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840719     DOI: 10.1016/j.tcb.2011.07.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  105 in total

Review 1.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

Review 2.  Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

Authors:  Andrea de Bartolomeis; Gianmarco Latte; Carmine Tomasetti; Felice Iasevoli
Journal:  Mol Neurobiol       Date:  2013-09-03       Impact factor: 5.590

3.  Epigenetic dysregulation of SHANK3 in brain tissues from individuals with autism spectrum disorders.

Authors:  Li Zhu; Xiaoming Wang; Xin-Lei Li; Aaron Towers; Xinyu Cao; Ping Wang; Rachel Bowman; Hyuna Yang; Jennifer Goldstein; Yi-Ju Li; Yong-Hui Jiang
Journal:  Hum Mol Genet       Date:  2013-11-01       Impact factor: 6.150

4.  NMDA-induced accumulation of Shank at the postsynaptic density is mediated by CaMKII.

Authors:  Jung-Hwa Tao-Cheng; Yijung Yang; K Ulrich Bayer; Thomas S Reese; Ayse Dosemeci
Journal:  Biochem Biophys Res Commun       Date:  2014-06-19       Impact factor: 3.575

Review 5.  Synapse assembly and neurodevelopmental disorders.

Authors:  Philip Washbourne
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

6.  Autism-associated SHANK3 missense point mutations impact conformational fluctuations and protein turnover at synapses.

Authors:  Michael Bucher; Stephan Niebling; Yuhao Han; Dmitry Molodenskiy; Fatemeh Hassani Nia; Hans-Jürgen Kreienkamp; Dmitri Svergun; Eunjoon Kim; Alla S Kostyukova; Michael R Kreutz; Marina Mikhaylova
Journal:  Elife       Date:  2021-05-04       Impact factor: 8.140

7.  The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-16

Review 8.  Modeling autism by SHANK gene mutations in mice.

Authors:  Yong-Hui Jiang; Michael D Ehlers
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

Review 9.  Therapeutic approaches for shankopathies.

Authors:  Xiaoming Wang; Alexandra L Bey; Leeyup Chung; Andrew D Krystal; Yong-Hui Jiang
Journal:  Dev Neurobiol       Date:  2013-10-11       Impact factor: 3.964

Review 10.  Modulation of behavior by scaffolding proteins of the post-synaptic density.

Authors:  Can Gao; Natalie C Tronson; Jelena Radulovic
Journal:  Neurobiol Learn Mem       Date:  2013-05-20       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.